SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001590750-20-000118
Filing Date
2020-12-04
Accepted
2020-12-04 16:34:47
Documents
15
Period of Report
2020-12-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mgen-20201202.htm   iXBRL 8-K 35586
7 mgen-20201202_g1.jpg GRAPHIC 5076
  Complete submission text file 0001590750-20-000118.txt   190997

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20201202.xsd EX-101.SCH 2444
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20201202_cal.xml EX-101.CAL 724
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20201202_def.xml EX-101.DEF 1657
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20201202_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20201202_pre.xml EX-101.PRE 12660
8 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20201202_htm.xml XML 10993
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 201370302
SIC: 8071 Services-Medical Laboratories